Time to Give Up on Cardioprotection?
نویسنده
چکیده
Both the incidence of acute ST-segment–elevation myocardial infarction (STEMI) and the mortality from STEMI have decreased over the last 3 decades. However, despite the success of reperfusion therapy by primary percutaneous coronary intervention (PCI) or thrombolysis, STEMI is still of significant concern. Although door-to-balloon time for primary PCI has declined, mortality has not, possibly because of an increasing number of older and sicker patients. Also, patients who survive an acute myocardial infarction (AMI) often develop heart failure, and the prevalence of heart failure is increasing in developed countries. Infarct size is the major determinant of patients’ outcome. Clearly, timely and complete reperfusion is the most effective way to limit infarct size. However, reperfusion also adds an additional reperfusion injury on top of ischemic injury, and it, thus, contributes to infarct size. Therefore, additional interventions and treatments on top of timely reperfusion are still needed to reduce infarct size and improve the clinical outcome of patients with AMI. Apart from acute STEMI (type 1 myocardial infarction), additional cardioprotection is also sought in elective PCI with the aim to reduce periprocedural myocardial infarction (type 4a) and in surgical coronary revascularization with the aim to reduce perioperative myocardial infarction (type 5); in some studies, cardioprotection was also sought in major cardiovascular surgery other than coronary artery bypass grafting (CABG). In the animal experiment, the conditioning phenomena are the most powerful cardioprotective, that is, infarct size reducing interventions. Ischemic preconditioning describes brief episodes of myocardial ischemia/reperfusion before the sustained coronary occlusion that results in infarction. Ischemic postconditioning describes brief episodes of coronary reocclusion/reperfusion in the immediate reperfusion phase after a sustained coronary occlusion that results in infarction. Remote ischemic conditioning describes brief episodes of ischemia/reperfusion of an organ or tissue remote from the heart; these episodes of distant ischemia/reperfusion can precede (preconditioning), follow (postconditioning), or occur in parallel (perconditioning) to the sustained coronary occlusion that causes the infarction. The most Review
منابع مشابه
Investigating the role of acute and repeated stress on remote ischemic preconditioning-induced cardioprotection
Objective(s): To study the effect of acute and repeated stress on cardioprotection-induced by remote ischemic preconditioning (RIPC).Materials and Methods: RIPC was induced by giving 4 short cycles of ischemia and reperfusion, each consisting of five min. The Langendorff’s apparatus was used to perfuse the isolated rat hearts by subjecti...
متن کاملThe Rise of Patient Safety-II: Should We Give Up Hope on Safety-I and Extracting Value From Patient Safety Incidents?; Comment on “False Dawns and New Horizons in Patient Safety Research and Practice”
Who could disagree with the seemingly common-sense reasoning that: “We must learn from the things that go wrong.”? Despite major investments to improve patient safety, relatively few evaluations demonstrate convincing reductions in risk, harm, serious error or death. This disappointing trajectory of improvement from learning from errors or Safety-I as it is sometimes known has led some research...
متن کاملCardioprotection of Preconditioning by Metabolic Inhibition in the Rat Ventricular Myocyte Involvement of k-Opioid Receptor
To determine whether opioid receptors (ORs) are involved in the delayed cardioprotection of ischemic preconditioning (IP), the effect of severe metabolic inhibition (MI) with a glucose-free buffer that contained sodium cyanide and 2-deoxy-D-glucose on the viability of isolated rat ventricular myocytes was first determined 20 hours after preconditioning with a sublethal metabolic inhibition (MIP...
متن کاملCardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor.
To determine whether opioid receptors (ORs) are involved in the delayed cardioprotection of ischemic preconditioning (IP), the effect of severe metabolic inhibition (MI) with a glucose-free buffer that contained sodium cyanide and 2-deoxy-D-glucose on the viability of isolated rat ventricular myocytes was first determined 20 hours after preconditioning with a sublethal metabolic inhibition (MIP...
متن کاملResveratrol Provides Cardioprotection after Ischemia/reperfusion Injury via Modulation of Antioxidant Enzyme Activities
In this study, we investigated the cardioprotective effects of resveratrol. Rats were intraperitoneally administered with resveratrol (25 mg/kg bw) or vehicle (ethanol 10%) for 7 days and their heart subjected to ischemia/reperfusion injury. Isolated hearts were langendorff perfused, left ventricular functions as heart rate and developed pressure, as well as, heart antioxidant status were deter...
متن کاملResveratrol Provides Cardioprotection after Ischemia/reperfusion Injury via Modulation of Antioxidant Enzyme Activities
In this study, we investigated the cardioprotective effects of resveratrol. Rats were intraperitoneally administered with resveratrol (25 mg/kg bw) or vehicle (ethanol 10%) for 7 days and their heart subjected to ischemia/reperfusion injury. Isolated hearts were langendorff perfused, left ventricular functions as heart rate and developed pressure, as well as, heart antioxidant status were deter...
متن کامل